165
Followers
2
Posts
127
KEYMED BIOSCIENCES INC
(HKEX: 2162)
Keymed Biosciences, Inc. is an investment holding company, which engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas. It operates through Hong Kong and China geographical segment. The company was founded on April 23, 2018 and is headquartered in Chengdu, China.
36.400 -
+0.800
(+2.25%)
Range
34.950 - 37.350
(6.87%)
Open
35.500
Previous Close
35.600
Bid Price
36.350
Bid Volume
('000)
4.5
Ask Price
36.450
Ask Volume
('000)
1.5
Volume
('000)
854.8
Value
31,019,900
Remark
-
Delayed prices. Updated at 06 May 2024 14:48.
Data powered by
View All Events
165
Loading Chart...
Please login to view stock data and analysis
